Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Prostatic Neoplasms × Diagnosis × Clear all

Phase

Status

Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 1 Prostatic Neoplasms 1

Interventions

Androgen Antagonists 11 darolutamide 6 Magnetic Resonance Spectroscopy 6 apalutamide 5 Specimen Handling 5 Radiosurgery 5 Brachytherapy 5 Docetaxel 4 Abiraterone Acetate 4 enzalutamide 3 Radiotherapy 3 Glutamate Carboxypeptidase II 3 Electroacupuncture 3 relugolix 2 pembrolizumab 2 luprolide acetate gel depot 2 bicalutamide 2 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2 Standard of Care 2 Resistance Training 2 Radiation 2 Prednisone 2 Leuprolide 2 Interviews as Topic 2 Gonadotropin-Releasing Hormone 2 Bone Density 2 Biopsy 2 Absorptiometry, Photon 2 ALT-803 2 testosterone 17 beta-cypionate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07526545 2026-04-13

UPRISE

University of Michigan Rogel Cancer Center

Phase NA Not yet recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡